Q53ER2 (Q53ER2_HUMAN) Unreviewed, UniProtKB/TrEMBL
Last modified
November 16, 2011.
Version 43.
History...
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Cross-refs·Entry infoCustomize order
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Cross-refs·Entry infoCustomize orderNames and origin
| Protein names | Submitted name: Cyclin D2 variant EMBL BAD97297.1 |
| Organism | Homo sapiens (Human) EMBL BAD97297.1 |
| Taxonomic identifier | 9606 [NCBI] |
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo |
Protein attributes
| Sequence length | 289 AA. |
| Sequence status | Fragment. |
| Protein existence | Evidence at transcript level |
General annotation (Comments)
| Sequence similarities | Belongs to the cyclin family. RuleBase RU000383 |
Ontologies
| Keywords | |
|---|---|
| Biological process | Cell cycle Cell division SAAS SAAS004367 |
| Molecular function | Cyclin SAAS SAAS006671 RuleBase RU000383 |
| Gene Ontology (GO) | |
| Biological process | cell cycle Inferred from electronic annotation. Source: UniProtKB-KW cell divisionInferred from electronic annotation. Source: UniProtKB-KW regulation of cyclin-dependent protein kinase activityInferred from electronic annotation. Source: InterPro |
| Cellular component | nucleus Inferred from electronic annotation. Source: InterPro |
| Molecular function | protein kinase binding Inferred from electronic annotation. Source: InterPro |
| Complete GO annotation... | |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | |||
Experimental info | ||||||||
|---|---|---|---|---|---|---|---|---|
| Non-terminal residue | 1 | 1 | EMBL BAD97297.1 | |||||
Sequences
| ||||||||||||||||||
References
| [1] | "Oligo-capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides." Maruyama K., Sugano S. Gene 138:171-174(1994) [PubMed: 8125298] [Abstract] Cited for: NUCLEOTIDE SEQUENCE. Tissue: Heart EMBL BAD97297.1. |
| [2] | "Construction and characterization of a full length-enriched and a 5'-end-enriched cDNA library." Suzuki Y., Yoshitomo K., Maruyama K., Suyama A., Sugano S. Gene 200:149-156(1997) [PubMed: 9373149] [Abstract] Cited for: NUCLEOTIDE SEQUENCE. Tissue: Heart EMBL BAD97297.1. |
| [3] | Totoki Y., Toyoda A., Takeda T., Sakaki Y., Tanaka A., Yokoyama S. Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE. Tissue: Heart EMBL BAD97297.1. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |
|---|---|
| EMBL GenBank DDBJ | AK223577 mRNA. Translation: BAD97297.1. |
| IPI | IPI00025810. |
| UniGene | Hs.376071. |
3D structure databases | |
| ModBase | Search... |
Protein-protein interaction databases | |
| STRING | Q53ER2. |
Protocols and materials databases | |
| StructuralBiologyKnowledgebase | Search... |
Phylogenomic databases | |
| GeneTree | ENSGT00560000076942. |
| HOVERGEN | HBG050837. |
Gene expression databases | |
| ArrayExpress | Q53ER2. |
Family and domain databases | |
| InterPro | IPR013763. Cyclin-like. IPR014400. Cyclin_A/B/D/E. IPR004367. Cyclin_C. IPR006671. Cyclin_N. [Graphical view] |
| Gene3D | G3DSA:1.10.472.10. Cyclin_related. 2 hits. |
| Pfam | PF02984. Cyclin_C. 1 hit. PF00134. Cyclin_N. 1 hit. [Graphical view] |
| PIRSF | PIRSF001771. Cyclin_A_B_D_E. 1 hit. |
| SMART | SM00385. CYCLIN. 1 hit. [Graphical view] |
| SUPFAM | SSF47954. Cyclin_like. 2 hits. |
| PROSITE | PS00292. CYCLINS. 1 hit. [Graphical view] |
| ProtoNet | Search... |
Entry information
| Entry name | Q53ER2_HUMAN | ||||||||
| Accession | Primary (citable) accession number: Q53ER2 | ||||||||
| Entry history |
| ||||||||
| Entry status | Unreviewed (UniProtKB/TrEMBL) | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||

Clusters with